Author | Primo N. Lara, MD | OncLive

Author | Primo N. Lara, MD

Articles

Dr. Lara on the Role of Sunitinib for Renal Cell Carcinoma

August 03, 2017

Video

Primo N. Lara, MD, associate director for translational research, UC Davis Comprehensive Cancer Center, discusses the role of sunitinib (Sutent) for patients with renal cell carcinoma (RCC).

Dr. Lara on the Potential Role of IDO Inhibitors in the Treatment of RCC

August 01, 2017

Video

Primo N. Lara, MD, associate director for translational research, UC Davis Comprehensive Cancer Center, discusses the potential role of IDO inhibitors in the treatment of patients with renal cell carcinoma.

Dr. Lara Discusses Epacadostat in Renal Cell Carcinoma

July 19, 2017

Video

Primo N. Lara, MD, associate director for translational research, UC Davis Comprehensive Cancer Center, discusses epacadostat in renal cell carcinoma.

Dr. Lara on Epacadostat Plus Pembrolizumab in RCC

June 23, 2017

Video

Primo N. Lara, MD, associate director for translational research, UC Davis Comprehensive Cancer Center, discusses epacadostat plus pembrolizumab (Keytruda) in patients with metastatic renal cell carcinoma (RCC).

x